Search results for "antagonist"

showing 10 items of 1660 documents

Pituitary-adrenal responses to corticotropin-releasing factor in late onset 21-hydroxylase deficiency

1990

Intravenous corticotropin-releasing factor (CRF) and adrenocorticotropin hormone (ACTH) were administered in patients with adult onset 21-hydroxylase deficiency to compare their diagnostic capability as well as to investigate hypothalamic-pituitary-adrenal function in this disorder. Responses of 17-hydroxyprogesterone, which were markedly elevated compared with controls, were identical with CRF and ACTH. However, intravenous ACTH resulted in higher androstenedione levels in comparison to CRF. Adrenocorticotropin hormone also resulted in decreased cortisol responses, confirming a defect in steroidogenesis, a finding that was not evident with CRF. Plasma ACTH responses to CRF were similar in …

AdultHirsutismendocrine systemmedicine.medical_specialtyAdolescentCorticotropin-Releasing HormoneLate onsetPeptide hormoneDecreased cortisolAdrenocorticotropic HormoneInternal medicineAdrenal GlandsHydroxyprogesteronesmedicineHumansTestosteroneIn patientAndrostenedioneAdrenal Hyperplasia Congenitalbiologybusiness.industry17-alpha-HydroxyprogesteroneAndrostenedione21-HydroxylaseObstetrics and GynecologyDiagnostic testEndocrinologyReproductive MedicinePituitary GlandSteroid Hydroxylasesbiology.proteinFemalebusinesshormones hormone substitutes and hormone antagonistsHormoneFertility and Sterility
researchProduct

Ovine corticotropin-releasing factor and dexamethasone responses in hyperandrogenic women

1990

Eighteen hyperandrogenic, hirsute women received ovine corticotropin-releasing factor (CRF; 1 microgram/kg) as well as a dexamethasone (DEX) suppression test. Nine of the 18 hirsute women exhibited increased DEX sensitivity. Plasma adrenocorticotropic hormone (ACTH) responses after ovine CRF were significantly lower in the DEX-sensitive subgroup, but serum androstenedione was higher. Baseline serum androgen levels could not predict DEX responses. A significant negative correlation existed between the suppression of androgens after DEX and the increase in ACTH after ovine CRF. The suppression of androgen correlated with the ratio of the increase in androgen to the increase in ACTH after ovin…

AdultHirsutismendocrine systemmedicine.medical_specialtyAdolescentCorticotropin-Releasing Hormonemedicine.drug_classMicrogramAdrenocorticotropic hormoneDexamethasoneAdrenocorticotropic HormoneInternal medicinepolycyclic compoundsAnimalsHumansMedicineAndrostenedioneDexamethasonehirsutismSheepbusiness.industryHyperandrogenismObstetrics and GynecologyAndrogen AntagonistsAndrogenmedicine.diseasePathophysiologyEndocrinologyReproductive MedicineAndrogensFemalebusinesshormones hormone substitutes and hormone antagonistsmedicine.drugFertility and Sterility
researchProduct

Physiological Estrogen Replacement May Enhance the Effectiveness of the Gonadotropin-Releasing Hormone Agonist in the Treatment of Hirsutism

1994

GnRH agonists (GnRH-A) have been used for the treatment of hirsutism in women with ovarian hyperandrogenism. However, significant side-effects, including vasomotor symptoms and bone loss, have prevented the long term use of this therapy. In this study, we evaluated the effects of low dose (physiological) estrogen replacement on the side-effects and clinical and hormonal parameters of 22 hirsute women with ovarian hyperandrogenism when treated with a long-acting GnRH-A, Decapeptyl. Ten patients with Ferriman-Gallwey (FG) scores averaging 13.4 +/- 1.5 were randomly assigned to be treated with Decapeptyl alone (3.75 mg, im, every 28 days for 6 months), and 12 other patients with FG scores aver…

AdultHirsutismendocrine systemmedicine.medical_specialtyAdolescentmedicine.drug_classEndocrinology Diabetes and MetabolismClinical BiochemistryOvaryMedroxyprogesterone AcetateGonadotropin-releasing hormoneBiochemistryGonadotropin-Releasing HormoneEndocrinologyGonadotropin-releasing hormone agonistInternal medicinemedicineHumansMedroxyprogesterone acetateEstrogen replacementConjugated Equine EstrogensTestosteronehirsutismTriptorelin PamoateVasomotorbusiness.industryEstrogen Replacement TherapyBiochemistry (medical)HyperandrogenismObstetrics and GynecologyDrug SynergismGeneral Medicinemedicine.diseaseMenstruationmedicine.anatomical_structureEndocrinologyEstrogenGonadotropins PituitaryAndrogensDrug Therapy CombinationFemalebusinesshormones hormone substitutes and hormone antagonistsHormonemedicine.drugObstetrical & Gynecological Survey
researchProduct

The endocrine pattern of late onset adrenal hyperplasia (21-hydroxylase deficiency)

1984

We describe 5 adult women with severe hirsutism due to late onset 21-hydroxylase deficiency. Diagnosis was performed on the finding of high serum 17-hydroxyprogesterone (17OHP) levels with a marked hyperresponse to an ACTH test. The endocrine study showed in most patients a gonadotropin behavior similar to that observed in classical polycystic ovary (PCO) syndrome. Prolactin levels were slightly increased in basal conditions and presented an exaggerated response to TRH stimulation.

AdultHirsutismendocrine systemmedicine.medical_specialtyAdolescentmedicine.drug_classEndocrinology Diabetes and MetabolismLate onsetEndocrinologyAdrenocorticotropic HormoneInternal medicineHydroxyprogesteronesmedicineHumansEndocrine systemGonadal Steroid HormoneshirsutismAdrenal Hyperplasia Congenitalbiologybusiness.industry17-alpha-HydroxyprogesteroneVirilization21-HydroxylaseLuteinizing Hormonemedicine.diseasePolycystic ovaryProlactinProlactinEndocrinologySteroid Hydroxylasesbiology.proteinFemaleSteroid 21-HydroxylaseFollicle Stimulating Hormonemedicine.symptomGonadotropinbusinesshormones hormone substitutes and hormone antagonistsJournal of Endocrinological Investigation
researchProduct

The short‐term effect of levocetirizine on quality of life, stress, and depression in itchy psoriasis patients

2019

AdultHistamine H1 Antagonists Non-Sedatingmedicine.medical_specialtyMEDLINEDermatologyLevocetirizineQuality of life (healthcare)Surveys and QuestionnairesInternal medicinePsoriasisHumansPsoriasisMedicineTerm effectDepression (differential diagnoses)Depressionbusiness.industryPruritusGeneral MedicineMiddle AgedHistamine H1 Antagonistsmedicine.diseaseCetirizineQuality of LifebusinessStress Psychologicalmedicine.drugDermatologic Therapy
researchProduct

Hormonal Alterations in Victimized Women Explained by Their Hostile Reactions in Coping with Couple Violence

2019

AbstractRecent studies have highlighted the dysregulation of hypothalamic-pituitary-adrenal (HPA) axis activity and its end products, cortisol and dehydroepiandrosterone (DHEA), in women with a history of intimate partner violence (IPV) victimization. These studies analyzed several coping styles, but they neglected to examine the use of violent strategies to confront IPV and the way these strategies affect HPA functioning. This latter proposal would be based on the gender symmetry model of IPV, which sustains that IPV is generally symmetrical, but that women’s violence tends to be a reaction to male violence. Hence, the main objective of the present study was to examine whether women’s viol…

AdultHypothalamo-Hypophyseal SystemLinguistics and LanguageCoping (psychology)HydrocortisoneeducationPoison controlSuicide preventionLanguage and Linguistics03 medical and health sciences0302 clinical medicineHostilityAdaptation PsychologicalInjury preventionHumansCrime VictimsGeneral PsychologyConfoundingHuman factors and ergonomicsDehydroepiandrosteronesocial sciences030227 psychiatrySpouse AbuseDomestic violenceFemalePsychologyhormones hormone substitutes and hormone antagonists030217 neurology & neurosurgeryClinical psychologyPsychopathologyThe Spanish Journal of Psychology
researchProduct

Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis

2011

Objective: To analyze the impact of LH administration on cycle outcome in ovarian stimulation with GnRH antagonists. Design: Randomized, open-label, controlled trial performed in two age subgroups. Recombinant (r) FSH versus rFSH + rLH administration was compared. Setting: University-affiliated private infertility clinic. Patient(s): Up to 35 years old (n = 380) and aged 36 to 39 years (n = 340), undergoing their first or second IVF cycle. Intervention(s): Recombinant LH administration since stimulation day 1. Main Outcome Measure(s): Implantation rate, ongoing pregnancy rate. Result(s): In the young population, implantation rates were similar: 27.8% versus 28.6%, odds ratio (OR) 1.03 (95% …

AdultInfertilitymedicine.medical_specialtyPregnancy Ratemedicine.drug_classmedicine.medical_treatmentGonadotropin-releasing hormone antagonistGonadotropin-Releasing HormoneOvulation InductionPregnancymedicineGnRH antagonistHumansEmbryo ImplantationSperm Injections IntracytoplasmicGynecologyPregnancyIn vitro fertilisationbusiness.industryObstetrics and GynecologyOdds ratioLuteinizing Hormonemedicine.diseaseRecombinant ProteinsConfidence intervalPregnancy rateReproductive Medicineluteinizing hormoneDrug Therapy CombinationFemaleOvarian stimulationFollicle Stimulating HormoneLuteinizing hormonebusinessInfertility Femalein vitro fertilizationMaternal Age
researchProduct

Effects of leptin on lipopolysaccharide-induced myometrial apoptosis in an in vitro human model of chorioamnionitis.

2011

Objective This study was aimed at assessing the role of leptin on human myometrium, by studying its receptor expression in pregnant myometrium and the interaction of leptin with inflammation-induced apoptosis. Study Design Myometrial samples were obtained from women with uncomplicated pregnancies who underwent cesarean delivery at term before labor onset. The effect of leptin on apoptosis was assessed by the incubation of myometrial strips with leptin (10 –10 to 10 –8 mol/L; 48 hours) before lipopolysaccharide treatment (10 μg/mL; 48 hours). Results Long and short leptin receptor isoforms were expressed in myometrial cells of pregnant women. Leptin prevented lipopolysaccharide-induced apopt…

AdultLeptinLipopolysaccharidesmedicine.medical_specialtyLipopolysaccharideReceptor expressionApoptosisIn Vitro TechniquesChorioamnionitischemistry.chemical_compoundYoung AdultPregnancyInternal medicinemedicineHumansLeptin receptorbusiness.industryLeptindigestive oral and skin physiologyMyometriumObstetrics and Gynecologymedicine.diseaseEndocrinologyChorioamnionitischemistryApoptosisMyometriumReceptors LeptinFemaleSignal transductionbusinesshormones hormone substitutes and hormone antagonistsAmerican journal of obstetrics and gynecology
researchProduct

New Obesity Indices and Adipokines in Normotensive Patients and Patients With Hypertension

2013

We compared the obesity parameters and selected adipokines—leptin, adiponectin, and resistin—in obese patients with hypertension and normotensive patients. A total of 67 nondiabetic obese outpatients were divided into 2 groups: A–hypertensive and B–normotensive. Serum levels of leptin, adiponectin, resistin, and insulin were measured. Weight, height, waist circumference, and hip circumference were measured to calculate waist-to-hip ratio (WHR), weight-to-height ratio, visceral adiposity index, and body adiposity index (BAI). Among patients with hypertension, significant positive correlations were observed between leptin and body mass index and BAI ( r = .31 and r = .63, respectively). In n…

AdultLeptinMalemedicine.medical_specialtyAdipokinePilot ProjectsIntra-Abdominal FatBody adiposity indexBody Mass IndexWaist–hip ratioPredictive Value of TestsInternal medicineobesity hypertension adipokines obesity indicesHumansMedicineResistinObesityAdiposityAdiponectinWaist-Hip Ratiobusiness.industryLeptinnutritional and metabolic diseasesMiddle Agedmedicine.diseaseObesityEndocrinologyCase-Control StudiesHypertensionFemaleResistinAdiponectinWaist CircumferenceCardiology and Cardiovascular MedicinebusinessBody mass indexBiomarkershormones hormone substitutes and hormone antagonistsAngiology
researchProduct

Expression of the obesity hormone leptin and its receptor correlates with hypoxia-inducible factor-1 alpha in human colorectal cancer.

2007

Background: The obesity hormone, leptin, has been found to play a role in development and proliferation of normal and malignant tissues. Leptin activity is mediated through the leptin receptor (ObR) that is often expressed in different human cancer cells. Previously, we found that the expression of leptin and ObR can be stimulated by hypoxia-mimetic agents. The aim of this study was to analyze the abundance of and relationships among leptin, ObR and hypoxia-inducible factor-1α (HIF-1α, transcriptional regulator) in human colorectal cancer. Materials and methods: We investigated the expression of leptin, ObR and HIF-1 a in colorectal cancer specimens from 135 patients who underwent curative …

AdultLeptinMalemedicine.medical_specialtyColorectal cancerAdipokineReceptors Cell SurfaceInternal medicinemedicineHumansObesityReceptorAgedAged 80 and overLeptin receptorbusiness.industryLeptindigestive oral and skin physiologyHematologyMiddle Agedmedicine.diseaseHypoxia-Inducible Factor 1 alpha SubunitObesityUp-RegulationGene Expression Regulation NeoplasticEndocrinologyOncologyHypoxia-inducible factorsDisease ProgressionReceptors LeptinFemalebusinessColorectal Neoplasmshormones hormone substitutes and hormone antagonistsHormoneAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct